Biotechnology Value Fund, L.P. Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotechnology Value Fund, L.P.

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Biomaven who wrote (83)	3/19/1998 11:41:00 PM
From: scaram(o)uche	Read Replies (3) of 4974

Peter: Yeah, I had a good day too. MOGN, CVAS, and nailed VGINF, bailing from 75% at 8 3/8 during the only 30 seconds on the day where one could do such. Keeping the remainder, as it's just too much fun watching Stevens et al. trying to hold it together with paper clips and bubble gum. Quite a show in Toronto. Stevens.... now there's a guy with vision. >>It would be interesting to look back historically to see just how many "walking wounded" biotechs have actually made it back from a near-death-experience<< Ready for a surprise??...... Idec is a good example. It's even tougher today. A company needs not only a viable product that meets a CLEAR need, but they also need ready access to a "platform". DM1 is a nifty little molecule. Not trying to say that it doesn't have utility. However, I'd say that IMGN's history is rather rich with stuff that, IMO, wasn't, to put it gently, in the best interests of the shareholder. And worse. If I were Lampert, I'd make you CEO. Or V1. Or maybe PB. Silsbee? You look good in a suit?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next